Matrix Metalloproteinase-13 - A Potential Biomarker for Detection and Prognostic Assessment of Patients with Esophageal Squamous Cell Carcinoma

Sedighi, Maryam; Aledavood, Seyed Amir; Abbaszadegan, MR; Memar, Bahram; Montazer, Mehdi; Rajabian, Majid; Gholamin, Mehran

추천

검색

자료유형: 학술저널

저자정보: Sedighi, Maryam (Division of Human Genetics, Immunology Research Center, Avicenna Research Institute) Aledavood, Seyed Amir (Department of Radiotherapy and Oncology, Omid Hospital, Mashhad University of Medical Sciences) Abbaszadegan, MR (Division of Human Genetics, Immunology Research Center, Avicenna Research Institute) Memar, Bahram (Department of Pathology, Omid Hospital, Mashhad University of Medical Sciences) Montazer, Mehdi (Department of Pathology, Omid Hospital, Mashhad University of Medical Sciences) Rajabian, Majid (Herbal biochemistry Department, payamnoor university- Faculty of basic science- Biology Group) Gholamin, Mehran (Division of Human Genetics, Immunology Research Center, Avicenna Research Institute)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제17권 제6호

발행연도: 2016.1

수록면: 2,781 - 2,785 (5page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Matric metalloproteinase (MMP) 13 gene expression is increased in esophageal squamous cell carcinomas (ESCCs) and associated with increasing tumor invasion, lymph node involvement and decreased survival rates. Levels of the circulating enzyme may be elevated and used as a marker of tumor progression. In this study, clinical application of MMP-13 serum levels was evaluated for early detection, prediction of prognosis and survival time of ESCC patients. Materials and Methods: Serum levels of MMP13 were determined by ELISA in 66 ESCC patients prior of any treatment and 54 healthy controls for comparison with clinicopathological data through statistical analysis with Man Whitney U and Log-Rank tests. In addition, clinical value of MMP13 levels for diagnosis was evaluated by receiver operating characteristic (ROC) test. Results: The serum level of MMP-13 in patients (>250 pg/ml) was significantly higher than in the control group (<100 pg/ml) (p value=0.004). Also the results showed a significant correlation between MMP-13 serum levels with tumor stage (p value = 0.003), depth of tumor invasion (p value=0.008), involvement of lymph nodes (p value = 0.011), tumor size (p value = 0.018) and survival time. While there were no significant correlation with grade and location of tumors. ROC analysis showed that MMP-13 level is an accurate diagnostic marker especially to differentiate pre-invasive/ invasive lesions from normal controls (sensitivity and specificity: 100%). Conclusions: These findings indicate a potential clinical significance of serum MMP13 measurement for early detection and prognostic assessment in ESCC patients.

#Esophageal SCC #MMP13 #serum marker #ELISA #diagnosis #prognostic assessment

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!